HLB Therapeutics Co.,Ltd.

115450 KRX Consumer Discretionary Consumer Discretionary
KOSDAQ
₩1,987.00
+1.38%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

✓Strengths

  • Low debt: debt-to-equity of 0.32.
  • Current assets comfortably cover current liabilities (current ratio 2.84).

!Watch-points

  • Thin interest cover: operating profit covers interest only about -0.7 times.
  • Return on equity is on the lower side at -6.1%.
  • Return on capital employed is on the lower side at -1.8%.
  • The company reported a net loss in the latest period.
  • Sales growth has been slow over five years (about 3% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreDistress zone
0.57

In Altman’s study, scores in this range were associated with a higher incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
3 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₩1,752억
Current Price₩ 1,987.00
High / Low₩ 4,160.00 / 0.00
Stock P/E-18.08
Book Value₩ 1,789.64
ROCE-1.75%
ROE-6.14%
Debt to Equity0.32
Current Ratio2.84
EPS₩ -109.90
PAT Margin-13.90%
ICR-0.65
Compounded Sales Growth
10 Years —
5 Years 2.79%
3 Years —
TTM —
Compounded Profit Growth
10 Years —
5 Years —
3 Years —
TTM —
Stock Price CAGR
10 Years —
5 Years —
3 Years —
1 Year —
Return on Equity
10 Years —
5 Years —
3 Years —
Last Year -6.14%
Educational data only. Not a recommendation to buy, sell or hold any security.